Market Size of Germany Cardiovascular Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 5.60 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Germany Cardiovascular Devices Market Analysis
The Germany Cardiovascular Devices Market is expected to register a CAGR of 5.6% during the forecast period.
The COVID-19 pandemic severely impacted the cardiovascular devices market as there was a disruption in supply chain management, and cardiac surgeries were on hold impacting the cardiovascular devices employed in the diagnosis and surgical procedure. For instance, an article titled "COVID-19: retrospective analysis of cardiac surgery capacity in German heart centers" published in the European Heart Journal in August 2022 stated that on 1 January 2020, in 53 German cardiac surgery departments 800 intensive care beds were allocated. This capacity was reduced to 595 beds in April 2021 by a 25.6% decrease. As a result, the number of operating rooms for cardiac surgery procedures was reduced from 207 to 152 (-26.9%) during the first two lockdowns. As elective surgeries and diagnostics were reduced, the pandemic adversely impacted cardiovascular devices used to treat and diagnose cardiovascular diseases.
In addition, the increasing burden of cardiovascular diseases and increased preference for minimally invasive procedures are actively affecting the growth of the studied market. As per the German Heart Surgery Report 2021 statistics, in 2021, there are about 161,261 cardiac procedures performed in Germany, out of 36,714 heart valve procedures and 19,490 are pacemaker and ICD-related procedures. Such a high number of cardiac procedures increases the demand for cardiovascular devices in Germany.
The technological advancements in cardiovascular devices, launches, partnerships, and acquisitions by key market players in Germany are likely to boost the studied market growth over the forecast period. For instance, in August 2022, AIBODY, one of the world's first Physiology-as-a-Service platforms, collaborated with the German Heart Centre Berlin (DHZB), a medical research institute specializing in cardiovascular disease. The collaboration is focused on the creation of cutting-edge solutions that will simplify congenital heart disease diagnosis and care. These initiatives are projected to augment the growth of cardiovascular devices in Germany.
Also, in October 2021, ReCor Medical Launched the Paradise Ultrasound Renal Denervation for the Treatment of Hypertension in Germany. The product launches and partnerships are likely to boost cardiovascular devices' growth in the country.
Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. however, stringent regulatory policies are likely to impede the market growth.
